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Sequential activation of MAP kinase cascade by angiotensin II in
opossum kidney cells. Angiotensin II (Ang IT) is a potent regulator of
proximal tubule functions, including transport, metabolism, and cell
proliferation. The opossum kidney (OK) cell line is a useful model of renal
proximal tubule. Mitogen-activated protein (MAP) kinases are rapidly
phosphorylated and activated in response to various agonists. We inves-
tigated Ang TI effects on serine/threonine kinase cascades in OK cells. The
major findings of the present study are that Ang II stimulated MAP kinase
kinase (MAPKK), MAP kinase (MAPK), and S6 kinase activities, and that
it increased phosphorylation of Raf-1 kinase and p42 MAP kinase in OK
cells. These stimulations of kinases were dose-dependent (from I0 to
10_li M). The time course of activation was sequential; the peak stimu-
lation was reached at 5 to 10 minutes for Raf-1 kinase, MAPKK and
MAPK, and at 20 minutes for S6 kinasc. The activation of MAPK was
inhibited by approximately 70% with prolonged 24-hour PMA pretreat-
ment or in the presence of calphostin C or H-7. Tyrosine kinase inhibitors
(genistein and herbimycin) did not inhibit Ang TI-induced MAPK activity.
This activation of MAPK was also inhibited via AT1 receptor antagonist,
Dup753 and pertussis toxin. This evidence suggests that the activation of
serine/threonine cascades by Ang II is largely dependent on PMA-
sensitive PKC, and is not dependent on tyrosine kinase and pertusis toxin.
Angiotensin II (Ang II) is a potent regulator of proximal tubule
functions, including transport [1, 2], metabolism [3], and cell
hypertrophy [4, 51. High-affinity Ang II binding sites and the
presence of type 1 Ang II (AT1) receptor mRNA has been
identified in the proximal tubule [6, 7]. To date two Ang II
receptor types have been identified: AT1 and AT2 receptors [8].
Only AT1 receptors, which bind to antagonist Dup 753, have been
evidenced in adult mammalian kidney [9]. In contrast, AT2
receptors, which bind the antagonist PD 123177, have been shown
to be predominantly expressed in fetal kidney, although their role
in renal development is still unknown [7]. Ang H induced 1P3
accumulation and Ca2 signaling, thus indicating that protein
kinase C (PKC) was activated by Ca2/digIycerides [10, 11]; Ang
II was also reported to inhibit cAMP generation [10]. Recently,
Ang II was reported to stimulate protein tyrosine phosphorylation
in vascular smooth muscle cells (VSMCs) [12], liver epithelial cells
[13], and rat renal mesangial cells [14]. Tsuda et al reported that
Ang II activates mitogen-activated protein kinase (MAPK) in
VSMCs [15].
Recently, models of signal transduction pathways have been
proposed in which a number of molecules act in series to activate
MAPK [16—20]. MAPK kinase (MAPKK) appears to be a con-
vergence point for two pathways: one originating at receptor and
non-receptor tyrosine kinases where information travels through
p2lras to Raf-1 and then to MAPKK, and the other originating at
G-protein-coupled signaling systems through MEKK (MAPKK
kinase) to MAPKK. After MAPKK is activated by one of the
pathways, MAPKs are activated, and they in turn may activate
pp9Orsk, transcription factors, or a variety of other potential
substrates [21—24]. Protein kinase C could be activated by either
the tyrosine kinase or G protein-dependent pathways through
phospholipase C gamma or beta, and may activate either Raf-1
kinase or MEKK [19, 20].
The OK cell line which is derived from opossum kidney is a
useful model of the renal proximal tubule, because OK cells have
retained several features of proximal tubular cells one of which is
parathyroid hormone (PTH)-stimulated cAMP synthesis [25].
Furthermore, Jourdain, Amiel and Friedlander reported that OK
cells possessed Aug TI receptors [26]. Since Ang II is a potent
regulator of proximal tubule function, it is of interest to determine
if the signaling pathway involving serine/threonine kinase cascade
is involved in the action of Ang II in OK cells. This will help us
further understand the signal transduction mechanisms of proxi-
mal tubule cells.
In this study, we investigated the Ang Il-induced signaling
pathway from cell membrane to cytosolic kinases known to be
kinases for transcription factors and other regulatory molecules.
We demonstrate that Aug II activates Raf-1 kinase, MAPKK,
MAPK, and S6 kinase, and phosphorylates Raf-1 kinase, MAPK,
and pp90rsk in OK cells. Therefore, we defined a signaling
pathway in OK cells activated by Ang II from the cell membrane
to serine/threonine kinases.
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Cell culture and preparation of extracts
OK cells originally purchased from the American Type Culture
Collection (Rockville, MD, USA) were grown in Dulbecco's
modified Eagle's medium with 10% fetal calf serum (FCS),
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penicillin at 100 lU/mi and streptomycin at 50 sg/ml, 20 mM
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES),
and 22 mi NaHCO3 (pH 7.4) in 5% C02-95% 02 at 37°C. For
experimental purposes the cells were changed to a medium
identical to the one above, the only difference being that 0.1%
bovine serum albumin (BSA) was substituted for FCS, and
incubated for 48 hours at 37°C.
After varying lengths of incubation time at 37°C in FCS-free
medium with Ang II or EGF, cells were scraped into a total
volume of 0.5 ml of extraction buffer containing 50 mivi -glyc-
erophosphate pH 7.3, 1.5 m'vi EGTA, 0.1 mivi Na3VO4, 1 mM
DY!', 10 sg/ml leupeptin, 10 sg/ml aprotinin, 2 tg/ml pepstatin
A, and 1 mivi benzamidine. The cells in the extraction buffer were
sonicated for 20 seconds (Sonicator, Central Co., Tokyo, Japan),
and centrifuged at 100,000 x g for 20 minutes at 4°C (Beckman,
TL-100 centrifuge). Supernatants (—0.3 mg/ml protein) were
stored frozen at —80°C.
Polyclonal antibodies
Antibodies against MAPK were prepared as described [271. We
confirmed antibody specificity using the peptide (RRITVEEAL-
AHPYLEQYYDPTDE) absorption experiment. The residues
used for the antigenic peptides were conserved in both p42 MAPK
and p44 MAPK. Antibodies against Raf-1 protein were raised
against a C-terminal peptide (amino acid sequence, CTLTFS-
PRLPVF). For immunization, the peptide was conjugated to
Keyhole Limpet hemocyanin with glutaraldehyde. Adult male
white New Zealand rabbits were immunized s.c. with the conju-
gate emulsified with either complete or incomplete Freund's
adjuvant, four times at two week intervals. The rabbit sera were
tested for the presence of antipeptide antibodies by enzyme-
linked immunoassay using plates coated with peptide only. Posi-
tive samples were further tested for specificity to Raf-1 protein by
Western blotting, using NIH3T3 cells overexpressing the protein
(data not shown). We also examined Western blotting of this
antibody using OK cells, and conducted peptide (CTLTTS-
PRLPVF) absorption experiments. The anti-phosphotyrosine an-
tibody was purchased from UBI (Lake Placid, NY, USA).
Kinase assays
OK cell cytosolic extracts (1.0 sg) were mixed with 4 ti of 2.0
mg/mi myeiin basic protein (MBP) for MAPK assays or 4 jsl of
18.0 mg/ml S6 peptide (RRRLSSLRA) (UBI) for S6 kinase
assays. Phosphorylation reactions were initiated by adding 8.3 d
of kinase assay buffer containing 50 mrvi J3-glycerophosphate pH
7.3, 3.75 mM EGTA, 0.15 mrvi Na3VO4, 1.5 mrvi DY!', 30 fLM
calmidazolium, 6 LM protein kinase inhibitor (PKI) peptide, 30
mM MgCI2, 0.1 mivt ATP, and 0.3 mvt [y-32P] ATP (specific activity
— 2000 cpm/pmol), and the assay mixture was incubated at 30°C
for 15 minutes. After the reaction was terminated by spotting 20
d of the assay mixture onto P-81 phosphocellulose filter paper
(Whatman, Maidstone, UK), the paper was washed several times
with 175 m phosphoric acid, and radioactivity was counted. To
correct for nonspecific phosphorylation, in filter paper assays of
kinase activity in cytosolic extracts, levels of phosphate incorpo-
ration measured in the absence of substrate were subtracted from
values measured in the presence of substrate. The percent of
increase of phosphate incorporation was 500 to 600% in MAP
kinase assay, which means that the background was around 16 to
20%. In S6 kinase assay, the percent increase was 500 to 700%,
and the background was around 14 to 20%. To examine whether
the time course of MAPK activation is changed by dephosphory-
lation, I LM okadaic acid was added to the medium and extraction
buffer.
MAPKKassays
OK cytosolic extracts (1.0 g) were mixed with 5.2 sl of 4.8
tg/ml MAPK (UBI), and phosphorylation reactions were initi-
ated by adding 8.3 jtl of the kinase assay buffer described above
without [y-32P] ATP. After incubation at 30°C for 10 minutes,
MBP phosphorylation was initiated by adding 4 d of 0.33 mg/mi
MBP and 0.3 mi [y-32P] ATP (specific activity —2000 cpm/pmol),
and the assay mixture was incubated at 30°C for 15 minutes. The
reaction was terminated by spotting 20 l of the assay mixture
onto P-81 phosphocellulose filter paper (Whatman), and radioac-
tivity was counted. To correct for nonspecific phosphorylation, in
this MAPKK assay, levels of phosphate incorporation measured
in the absence of exogenous MAPK protein were subtracted from
values in the presence of exogenous MAPK protein. The increase
of phosphate incorporation was 300 to 400% in MAPKK assay,
which means that the background was around 25 to 33%.
Immunoprecipitation
After varying lengths of incubation time at 37°C in Ang II
containing medium, cells were lysed into a total volume of 0.5 ml
of lysis buffer containing 10 mivi /3-glycerophosphate, pH 7.4, 1.0
mM EDTA, 5.0 m'vi EGTA, 0.15 m'vi Na3VO4, 2.0 mM DY!',
20 mrvi HEPES, pH 7.4, 0.5% (vol/vol) Nonidet P-40, 0.1%
(wt/vol), sodium deoxycholate, 1 mrvi phenylmethylsulfonyl fluo-
ride (PMSF), 10 tg/ml aprotinin, and 10 jsg/ml leupeptin. Lysates
were allowed to remain on ice for 30 minutes, and were then
centrifuged at 15,000 X g for 30 minutes at 4°C. Supernatants
were incubated for two hours at 4°C with 3 il of rabbit anti-
phosphotyrosine antibody (UBI) and protein G-Sepharose. Im-
mune complexes were recovered by centrifugation. Pellets were
washed three times with 50 mM Tris, pH 8.5, 150 mM NaCl, 0.02%
NaN3, 1.0% Nonidet P-40, 0.5% sodium deoxycholate, 0.5 mvi
Na3 V04, 5 mivi DY!', and 1 mM PMSF. The pellets were solubi-
lized in SDS-sample buffer. The samples were resolved in SDS-
polyacrylamide gel electrophoresis. The proteins were then trans-
ferred to an Immobilon P membrane (Daiichikagaku, Tokyo,
Japan). To detect MAPK, the membrane was incubated with
anti-MAPK antibody at a dilution of 1:500 in TBS containing
0.1% Tween 20 for two hours at 37°C, and visualized with
125!-goat anti-rabbit IgG (0.5 iCi/ml). 125 I-labeled MAPK protein
bands were visualized by autoradiography.
Raf protein was immunoprecipitated with a rabbit anti-Raf-1
protein. Immune complexes were obtained using exactly the same
protocol as described above. The pellets were used in immune
complex kinase assays as prescribed by Siegel et a! [28] in 50 1id
volume of 10 mM Tris-HCI pH 7.5, 10 mrvi MnCl2, 150 mM NaC1,
10 mM MgCl2, 2 mM DDT, and 1.2 mivi [y-32P1 ATP (specific
activity —2000 cpm/pmol), for five minutes at 37°C. Reactions
were terminated by adding SDS and boiling for five minutes. The
samples were then resolved by SDS-polyacrylamide gel electro-
phoresis, and phosphorylation of Raf-l protein was detected by
autoradiography. To examine whether the time course of Raf-1
activation is changed by dephosphorylation, 1 tM okadaic acid
was added to the extraction buffer.
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Down-regulation of protein kinase C (PKC) and tyrosine
kinase activities
To deplete the PMA-sensitive PKC, we preincubated the OK
cells with 100 nM phorbol 12-myristate 13-acetate (PMA) for 24
hours before incubation with Ang II. To inhibit PKC activity, we
incubated the OK cells in the presence of 100 nM calphostin C or
10 tM 1-(5-isoquinolinesulfonyl)-2-methylpinerazine (H-7) for 30
minutes before Ang II incubation. These inhibitors were also
added to Ang IT-containing medium. To inhibit tyrosine kinase
activity, we incubated OK cells in the presence of 20 .LM genistein
or 1 mM herbimycin for 60 minutes before Ang II incubation.
These inhibitors were also added to Ang Il-containing medium.
To investigate receptor subtypes, we incubated OK cells in the
presence of 100 nM Dup 753, a specific antagonist for AT1, for 30
minutes. Dup 753 were also added to Ang Il-containing medium.
We incubated OK cells in the presence of 100 ng/ml pertussis
toxin for 30 minutes to investigate G-protein coupling. Pertussis
toxin was also added to Ang Il-containing medium. The cells were
lysed and centrifuged, and supernatants were assayed for MAPK
activity as described above.
Effects of 8-bromo-cAMP and forskolin to Ang Il-stimulated
MAP kinases
To investigate the effects of cAMP on Ang IT-stimulated MAPK
activity in OK cells, we used 8-bromo-cAMP and forskolin. We
incubated OK cells in the presence of iO M forskolin and i04
M 8-bromo-cAMP for 30 minutes. 8-bromo-cAMP and forskolin
was also added to Ang Il-containing medium. The cells were lysed
and centrifuged, and supernatants were assayed for MAPK activ-
ity as described above.
Detection of pp9Orsk autophosphoylation
After varying lengths of incubation time at 37°C in Ang
11-containing medium, cells were lysed into a total volume of 0.5
ml of lysis buffer containing 10 mt'vi /3-glycerophosphate, pH 7.4,
1.0mM EDTA, 5.0 mrvi EGTA, 0.15 ifiM Na5VO4, 2.0 mvi DTT, 20
mM HEPES, pH 7.4, 0.5% (vol/vol) Nonidet P-40, 0.1% (wt/vol),
sodium deoxycholate, 1 mvt phenylmethylsulfonyl fluoride
(PMSF), 10 g/m1 aprotinin, and 10 g/ml leupeptin. Lysates
were allowed to remain on ice for 30 minutes, and were then
centrifuged at 15,000 x g for 30 minutes at 4°C to obtain the
cytosolic fraction of the cell lysate. The supernatants were used in
autophosphorylation assays as prescribed by Siegel et a! 28].
Reactions were carried out in 50 l volumes with 10 mrvi Tris-HC1
pH 7.5, 10 mivi MnCl2, 150 mrvi NaCI, 10 mivi MgC12, 2 mrvi DDT,
and 1.2 mi [y-32P] ATP (specific activity —2000 cpm/pmol), for
five minutes at 37°C. Reactions were terminated by adding SDS
and boiling for five minutes. The samples were then resolved by
SDS-polyacrylamide gel electrophoresis, and phosphorylation was
detected by autoradiography.
[3Hj thymidine incorporation
OK cells were plated in 24-well plates, incubated in serum-free
medium for 48 hours, and then stimulated for 24 to 72 hours with
daily doses of Ang II or EGF (every 24 hr). For the last four
hours, cells were pulsed with 1 .tCi [3H] thymidine (Amersham,
Arlington Heights, IL, USA). After the cells were washed three
times in ice-cold PBS, they were then precipitated two times with
10% trichloroacetic acid (TCA), redissolved in 0.5 M NaOH with
0.1% Triton X-100, and counted in Aquasol-2 scintillation cock-
tail (NEN Research Products, Boston, MA, USA).
[3H] leucine incorporation
OK cells were plated in 24-well plates, incubated in serum-free
medium for 48 hours, and then stimulated for 24 to 72 hours with
daily doses of Ang II or EGF (every 24 hr). For the last 12 hours,
cells were pulsed with 5 tCi [3H] leucine (Amersham). After the
cells were washed three times in ice-cold PBS, they were then
precipitated two times with 10% trichloroacetic acid (TCA),
redissolved in 0.5 M NaOH with 0.1% Triton X-100, and counted
in Aquasol-2 scintillation cocktail (NEN Research Products).
Statistics
The results are given as means SEM. The differences were
tested using analysis of variance. P < 0.05 was considered
significant.
Results
Effect of Ang lIon [3HJthymidine incorporation and [3H]leucine
incorporation into OK cells
Treatment with 10—'°--- to 10_6 M Ang II for 48 hours did not
change [3Hjthymidine incorporation, as shown in Figure 1A.
Similar results were obtained after 24 hours and 72 hours (data
not shown). Treatment with 10 10 EGF for 48 hours significantly
increased [3HJ thymidine incorporation (Fig. 1A). Treatment with
10_b0 to 10—6 M Ang II for 48 hours significantly increased
3HJleucine incorporation (Fig. 1B). Similar results were obtained
after 24 hours and 72 hours (data not shown).
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Fig. 1. Effect of Ang lIon [3H] thymidine
incorporation and [3H1 leucine incorporation into
OK cells. A. OK cells were incubated with
iO°— to 106 M Ang II or 10b0 M EGF for
48 hours, and were pulsed with [3H] thymidine
for four hours (N = 5, mean SEM; P <
0.001). B. OK cells were incubated with 10_b0_
to 10—6 M Ang II for 48 hours, and were pulsed
with [3H] leucine for 12 hours (N = 5, mean
SEM; < 0.001).
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Fig. 2. Ang II stimulation of the phospho,ylation of Raf-] kinase in OK cells. A. OK cells were incubated with i0 M Ang II in OK cells for 5, 10, 15,
30, and 60 mm. B. OK cells were incubated with 1O M Ang II in the presence of 10' M okadaic acid for 5, 10, 15, 30, and 60 mm. C. OK cells were
stimulated with various concentration of Ang II, and MAPK activity was stimulated dose-dependently. Autophosphorylation of Raf-1 kinase was
detected in anti-Raf-1 kinase immunoprecipitants incubated with [y-32j ATP. D. The left lane is a Western blot with anti-Raf-1 kinase antibody from
OK cells lysate, and the right lane is a Western blot with anti-Raf-1 kinase in the presence of peptide (CTLTTSPRLPVF).
Ang II stimulation of the phosphoiylation of Raf-1 kinase
in OK cells
To examine AT Il-stimulated autophosphorylation of Raf-1
kinase, OK cells were incubated with 10— to i0 M Ang II for
10 minutes (Fig. 2). Autophosphorylation of Raf-1 kinase was
detected in anti-Raf-1 kinase immunoprecipitants incubated with
[gamma-32P] ATP. Figure 2A shows the time course of autophos-
phorylation of Raf-1 kinase induced by io— M Ang II in OK cells.
Autophosphorylation of Raf-1 kinase increased to a maximum
level at 5 to 10 minutes following Arig II incubation, and then
gradually decreased up to 60 minutes. In the presence of 10_6 M
okadaic acid, increased autophosphorylation persists up to 60
minutes (Fig. 2B). As shown in Figure 2C, autophosphorylation of
Raf-1 kinase is dose-dependent (10 to 106 M). To confirm
the specificity of the antibody, we examined Western blotting in
OK cells and conducted a peptide (CTLTTSPRLPVF) absorption
experiment. As shown in Figure 2D, we obtained a clear single
band, and the band disappeared in the presence of the peptide.
Ang II stimulation of MAPKK activity
Raf-1 kinase is reported to phosphorylate MAPKK [21]. Raf-1
kinase, MEKK, and MAPKK are therefore believed to be key
enzymes between cell membrane to MAPK. We investigated the
time course for activation of MAPKK stimulated by i0 M Ang
II at 5, 10, 15, 30, and 60 minutes. MAPKK activity reached a
maximum level at 5 to 10 minutes following start of Ang II
incubation (Fig. 3A). This stimulation was dose-dependent from
10_11 to 106 M Ang II (Fig. 3B). The EC5O value of Ang II
stimulation of MAPKK activity was iO M Ang II.
Ang II stimulation of MAPK activity and phosphoiylation of p42
MAP kinase protein
We studied whether Ang II was able to activate MAPK activity
and the time course of MAPK stimulation by Ang II is shown in
Figure 4A. MAPK activity was increased by iO M Ang II and
reached maximum level at 5 to 10 minutes following the start of
Ang II incubation. In the presence of 106 M okadaic acid, the
elevation of MAPK activity persisted up to 60 minutes (Fig. 4A).
To study the concentration dependence of Ang II stimulation of
MAPK activity, OK cells were treated with varying concentrations
of Ang II for 10 minutes and MAPK activity was determined.
MAPK activity was dependent on the concentration of Ang II
(Fig. 4C); stimulated activity was initially significant at 10_b M,
half-maximal at l0 M and maximal at iO M. Treatment of OK
cell with EGF 10 ' to 106 M also increased MAPK activity dose
dependently (Fig. 4B).
To compare the effects of LPA on MAPK activity with those of
Ang II, we examined the time course experiment with 10 M
LPA. As shown in Figure 4C, MAPK activity was increased by
iO M LPA, and reached a maximum level at five minutes
following the start of LPA incubation.
To further examine Ang Il-stimulated tyrosine phosphorylation
of MAPK, OK cells were incubated with Ang II. In anti-phospho-
tyrosine immunoprecipitants probed with anti-MAPK antibody,
tyrosine phosphorylation of p42 MAPK increased from five
minutes and reached maximum level at 10 minutes following start
of Ang II incubation (Fig. 4D). Tyrosine phosphorylation of p44
MAPK was not detected in our experimental conditions. To
confirm the specificity of the antibody, we examined Western
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(Fig. SB). The EC5O value of Ang II stimulation of S6 kinase
activity was 10 M Ang II. To examine Ang Il-stimulated
autophosphorylation of pp90rsk, OK cells were incubated with
10b0 to 10_6 M Ang II. Autophosphorylation of pp90rsk kinase
was detected in SDS-PAG gel analysis of cytosolic cell lysates
incubated with [gamma-32P] ATP. Figure 5C shows the time
course of autophosphorylation of pp90rsk in response to i0 M
Ang II in OK cells. Autophosphorylation of pp9orsk increased to
a maximum level at 30 minutes. As shown in Figure 5D, auto-
phosphorylation of pp90rsk was dose-dependent from 10_b to
10—6 M Ang II.
Effects of PMA, caiphostin C, H-7, genistein, herbimycin, pertussis
toxin and Drip 753 on Ang 11-stimulated MAPK activity
in OK cells
50 60 70 We questioned whether MAPK is activated by Ang II via
PKC-independent or -dependent pathways (Fig. 6). Two indepen-
dent PKC inhibitors were used, calphostin C and H-7, and PKC
depletion was achieved by PMA pretreatment. PMA stimulated
and Ang II activated MAPK activity in OK cells that were not
• pretreated with PMA. However, when OK cells were pretreated
with 100 nM PMA for 24 hours, MAPK activity stimulated by Ang
II decreased by approximately 76.6 13.1% (N = 5, mean SEM)
• compared with OK cells that were not pretreated. PMA stimula-
tion of MAPK activity decreased significantly in PMA-pretreated
OK cells, suggesting that PKC was indeed depleted. Thirty
minutes of prior treatment with caiphostin C, a potent PKC
inhibitor, inhibited Ang IT-induced MAPK activation by 63.3
15.9% (N = 5, mean 5EM). Thirty minutes of prior treatment
with H-7, a potent PKC inhibitor, inhibited Ang TI-induced
MAPK activation by 67.5 17.3% (N = 5, mean suM). These
data demonstrate that Ang IT-induced MAPK activation is mainly
dependent on the activation of PKC.
PKC and Raf-1 kinase could be activated by either the tyrosine
kinase or G-protein-coupled receptor pathways [16, 19, 20]. To
distinguish between these two possibilities, two tyrosine kinase
inhibitors, genistein and herbimycin were used. We studied Ang
Il-stimulated MAPK activity in OK cells incubated with genistein
and with herbimycin, inhibitors of tyrosine kinase for 60 minutes,
before incubation with io M Ang II. As shown in Figure 6,
incubation of OK cells with i0— M Ang II in the presence of 20
1M genistein or 1 mM herbimycin resulted in a small decrease
(13.3 5.8%, 11.5 4.6%, respectively) of Ang Il-stimulated
MAPK activity.
We examined whether MAPK is activated by Ang II via AT1
receptor or AT2 receptor. As shown in Figure 6, when OK cells
were pretreated with 100 flM Dup 753, the increment of MAPK
activity stimulated by Ang II decreased by approximately 67.3
20.4% (N = 5, mean 5EM) compared with the kinase activity
without pretreatment. These data demonstrate that Ang II-
induced MAPK activation is mainly via AT1 receptor.
We next examined whether MAPK is activated by Ang II via
pertussis-toxin-sensitive pathways. As shown in Figure 6, when
OK cells were pretreated with 100 nglml pertussis toxin, the
increment of MAPK activity stimulated by Ang TI was inhibited by
approximately 79.2 17.1% (N = 5, mean sEM) compared with
the kinase activity without pretreatment. These data demonstrate
that a pertussis toxin-sensitive G protein mediates the stimulation
of MAPK by Ang IT.
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Fig. 3. Ang II stimulation of MAPKK activity. A. OK cells were incubated
with io— M Ang II for 5, 10, 15, 30, and 60 minutes. MAPKK activity was
measured after preincubation with or without MAPK protein. B. OK cells
were stimulated with various concentration of Ang II, and MAPKK
activity was stimulated dose-dependently. For A and B, N = 5, mean
SEM.
blotting in OK cells and conducted a peptide (RRITVEEALAH-
PYLEQYYDPTDE) absorption experiment. As shown in Figure
4D, clear bands of 42 and 44 kD were obtained, and the bands
disappeared in the presence of the peptide.
Ang II stimulation of S6 kinase activity and the phosphorylation of
pp9Orsk in OK cells
S6 kinase is known to be phosphorylated and activated by
MAPK [22—24]. S6 kinase may act as a mediator between signal
transduction pathways and the intranuclear events. Thus, the S6
kinase activity induced by Ang II was measured. The time course
for activation of S6 kinase by i0— M Ang II was examined at 5, 10,
15, 30, and 60 minutes. S6 kinase activity was stimulated from five
minutes and reached a maximum level at 30 minutes (Fig. 5A).
This stimulation was dose-dependent from 10 to 10-6 M Ang TI
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Fig. 4. AngII stimulation of MAPK activity and phosphoylation of p42 MA PK protein. A. OK cells were incubated with iO- M Ang IT (O.—O) in OK
cells for 5, 10, 15, 30, and 60 mm. OK cells were also incubated with iO M Ang II in the presence of i0' M okadaic acid (O———O) for 5, 10, 15, 30,
and 60 mm. B. OK cells were stimulated by various concentrations of Ang 11(0) or EGF (•), and MAPK activity was stimulated dose-dependently.
C. OK cells were incubated with 10 M EGF (I) or 10 M LPA (A) for 5, 10, 15, 30, and 60 minutes. D. OK cells were incubated with Ang II for
10 minutes. Tyrosine phosphorylation of MAPK was observed in anti-phosphotyrosmne immunoprecipitants probed with anti-MAPK. The left lane is a
Western blot with anti-MAPK antibody of OK cells lysate in absence or presence of peptide.
Inhibition of Ang 11-stimulated MAP kinases by 8-bromo-cAMP
and forskolin
To investigate the effects of cAMP on Ang Il-stimulated MAPK
activity in OK cells, 8-bromo-cAMP and forskolin was used (Fig.
7). Incubation of OK cells with forskolin or 8-bromo-cAMP did
not affect the amount of MAP kinase activity (data not shown).
However, iO M forskolin and i04 M 8-bromo-cAMP reduced
the Ang IT-dependent increase of MAP kinase activities to 36
9.1% and 47 11.4%, respectively.
Discussion
The major findings of the present study are that Ang II
stimulates MAPKK, MAPK and S6 kinase activity, and increases
phosphorylation of Raf-1 kinase, p42 MAPK, and pp90rsk in OK
cells. These Ang Il-stimulations of kinase activity are dose depen-
dent. The time course of activation is sequential; Raf-1 kinase,
MAPKK, and MAPK peak at 5 to 10 minutes, and S6 kinase peaks
at 30 minutes. Activation of MAPK is inhibited by 70% with PMA
pretreatment or in the presence of calphostin C or H-7. Tyrosine
kinase inhibitors (genistein and herbimycin) do not significantly
inhibit Ang IT-induced MAPK activity. Activation of MAPK is
also inhibited via AT1 receptor antagonist, Dup753, and pertussis
toxin. Forskolin and 8-bromo-cAMP reduced the Ang lI-depen-
dent increase of MAPK activities. This evidence suggests that the
activation of serine/threonine cascades by Ang II is largely
dependent on PMA-sensitive PKC, and that it is not dependent on
tyrosine kinase.
Angiotensin II is a potent regulator of proximal tubule func-
tions, including transport [1, 2], metabolism [3], and cell hyper-
trophy [4, 5]. High-affinity Ang II binding sites and the presence of
AT1 receptor mRNA has been identified in the proximal tubule
[6, 7]. Regarding signal transduction pathways linked to Ang IT
receptors, accumulation of 1P3 and activation of protein kinase C
(PKC) system have been demonstrated [10, 11]. Recently, Ang II
was reported to stimulate protein tyrosine phosphorylation in
vascular smooth muscle cells (VSMCs) [12], liver epithelial cells
[13], and rat renal mesangial cells [14]. Tsuda et al reported that
Ang II activates MAPK in VSMCs [15].
This study demonstrates that Ang II stimulates serine!threonine
kinase cascades in OK cells. It is of interest to determine the
signal transduction pathway from Ang II receptor to nucleus.
MAPK is activated by MAPKK [16, 19, 20]. MAPKK appears to
be a convergence point for two pathways, one originating at
receptor and non-receptor tyrosine kinases, and the other origi-
nating at G-protein-coupled signaling system through PKC and
MAPKK [19, 20]. Ang II stimulates both PKC and tyrosine
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Fig. 5. Ang II stimulation of S6 kinase activity
and phosphotylation of pp9Orsk. A. OK cells
were incubated with iO- M Ang II for 5, 10,
15, 30, and 60 minutes. S6 kinase activity was
measured after preincubation with or without
S6 substrate. B. OK cells were stimulated with
various concentrations of Ang II, and S6 kinase
activity was stimulated dose-dependently (A
and B, N = 5, mean SEM). C. OK cells were
incubated with 10 M Ang II for 5, 10, 15, 30,
and 60 mi Autophosphorylation of pp9O rsk
was detected in cytosolic cell lysate, incubated
with [y-32P] ATP. D. Autophosphorylation of
pp9Orsk was detected in OK cells incubated
with various concentrations of Ang II for 30
mm.
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phosphorylation [10—14]. Thus, MAPK stimulation by Ang II may
be mediated by both pathways. After MAPKK is activated by one
of the pathways, MAPK is activated, which in turn may activate
pp90rsk, transcription factors, or a variety of other potential
substrates [21—24].
Our study demonstrates that Ang II stimulates serine/threonine
kinase cascades, and that the activation of MAPK is largely
Fig. 6. Effects of PMA, calphostin C, H- 7,
genistein, herbimycin, pertussis toxin, and Dup
753 on Ang lI-stimulated MAP kinase activities
in OK cells. OK cells were incubated with iO
M Ang Jim the presence or absence of 10—6 M
PMA for 24 hours. Prior treatment with
Calphostin C or H-7 significantly inhibited Angj H-induced MAPK activation. Incubation of OKcells with Ang 11 in the presence of genistemn or
herbimycin resulted in a partial decrease ofI a) 0
-
>. MAP kinase activity. When OK cells were
E . pretreated with pertussis toxin or Dup 753, the
MAPK stimulation of Ang II was decreasedi significantly compared with the kinase activity
without pretreatment (N 5, mean SCM).
dependent on PMA-sensitive PKC in OK cells. The presence of
many forms of PKC has been reported [29]. The presence of
conventional PKCs (PKC) has been found in renal epithelial cells
(MDCK cells). The atypical PKCs (PKC), which are reportedly
PMA-insensitive, are also expressed in MDCK cells [29]. Our data
suggest that PMA pretreatment and PKC inhibitors fail to com-
pletely inhibit Ang 11-induced MAPK activation. One possible
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explanation is that PMA-insensitive PKC may play a role in
MAPK pathway, and another explanation is that MAPK is
activated by tyrosine kinase pathway.
Recently, conventional PKC was reported to activate Raf-1
kinase by direct phosphorylation [30]. The Raf-1 kinase then
activates MAPKK, and MAPKK activates MAPK. MAPKK was
found to be phosphorylated by Raf-1 kinase [21]. In VSMCs and
epithelial cells, Ang II binding to the AT1 receptor stimulates
phosphatidylinositol-specific phospholipase C activity through the
activation of at least one closely coupled G-protein [11, 31]. This
results in the generation of the second messengers inositol
triphosphate and diacylglycerol, which are involved in intracellu-
lar Ca2 mobilization and PKC activation, respectively. Thus, it is
possible that Ang II activates conventional PKC, the kinase
phosphorylates Raf-1 kinase, the Raf-1 kinase activates MAPKK,
and then the MAPKK activates MAPK in OK cells. Our time-
course results provide evidence to support this sequential activa-
tion. We showed that PMA-pretreatment, H-7, and caiphostin C
all inhibited Ang lI-induced MAPK activation. Tyrosine kinase
inhibitors (genistein and herbimycin) do not inhibit Ang II-
induced MAPK activity. This evidence suggests that the activation
of serine/threonine cascades by Ang II is largely dependent on
PMA-sensitive PKC, and that is not dependent on tyrosine kinase.
The physiological function of MAPK in epithelial cells is not
well known. Recently, MAPK was reported to phosphorylate
phospholipase A2 and regulate its activity. Phospholipase A2 is the
key enzyme in the generation of prostaglandin (PG), leukotrienes
and thromboxanes. Ang II was known to stimulate prostaglandin
synthesis in renal epithelial cells [32]. In rabbit proximal tubular
cells, Ang II increased synthesis of PGE2, PGF2,, and 6-keto-
PGF1 [32]. MAPK, which was stimulated by Ang II, may
phosphorylate and activate phospholipase A2, and may regulate
cellular function in OK cells. Recently, cAMP has been reported
to inhibit MAP kinase cascade [33, 3I. It has been reported that
there is an antagonism between protein kinase A (PKA) and MAP
kinase cascade [35]. There are also reports that a possible
mechanism of the cAMP and PKA inhibition of MAP kinase
cascade is cAMP's inhibition of the signal transduction from Ras
via its prevention of Ras-dependent activation of Raf-1 kinase
autophosphorylation [33]. Ang II was reported to inhibit cAMP
generation in renal cortex [10]. Our results demonstrate that
cAMP inhibits Ang Il-stimulated MAP kinase cascades. The
physiological functions of this cross-talking have not yet been
clarified, but they may regulate some negative feedback system in
hypertrophy or transport.
The present study demonstrates that Ang II activates S6 kinase
and phosphorylates pp90rsk in OK cells. Ang II was reported to
activate S6 kinase activity in cultured rat renal proximal tubule
cells [36]. Harris demonstrated that Ang II increases protein
synthesis in the absence of mitogenesis [36], and S6 kinase has
been identified as one potentially important lamin kinase [37]. S6
kinase may act as a mediator between the signal transduction
pathways and the intranuclear events, because the lamins are
intermediate filament proteins that form a fibrous layer at the
periphery of the nucleus. Furthermore, it has been shown that
MAPK is able to phosphorylate and activate c-Jun [38, 39]. MAPK
was recently reported to phosphorylate p62TCF, which binds the
serum responsive element (SRE) in the promoter region of c-fos
gene [40]. Thus, activation of MAP kinase may play a role in Ang
Il-induced c-fos mRNA induction. Transcription factors also can
serve as substrates for the MAP and S6 kinases [39, 40]. Hence, it
is possible that these kinases play a role in regulating gene
transcription [38—40] and protein synthesis. Thus, it is a fascinat-
ing hypothesis that serine/threonine kinase cascades mediate the
signal transduction pathway from AT1 receptor to gene transcrip-
tion and protein synthesis.
Acknowledgments
This work was partly supported by a Grant-in-Aid for General Scientific
Research in Japan (05837007, 04454234, and 04670383), and by the
Mochida Memorial Foundation for Medical and Pharmaceutical Research
in 1992 and 1994.
Reprint requests to Yoshio Terada, M.D., Second Department of Internal
Medicine, Tokyo Medical and Dental University, 5-45 Yushima 1-chome,
Bunkyo-ku, Tokyo 113, Japan.
References
1. HARRIS PJ, YOUNG JA: Dose-dependent stimulation and inhibition of
proximal tubular reabsorption by angiotensin II in the rat kidney.
Plugers Arch 367:295—297, 1977
2. NAvAR LG, CARMINES PK, HUANG WC, MITCHELL KD: The tubular
effects of angiotensin II. Kidney mt 31(Suppl 20):S81—S88, 1987
3. GOLIGORSKY MS, OSBORNE D, HOWARD T, HRusI KA, KARL 1K:
Hormonal regulation of gluconeogenesis in cultured proximal cells:
Role of cytosolic calcium. Am J Physiol 253:F802—F809, 1987
4. NORMAN J, BADIE-DEZFOOLY B, NORD EP, KURTZ I, SCHLOSSER J,
CHADHARI A, FINE LG: EGF-induced mitogenesis in proximal tubular
cells: Potentiation by angiotensin II. Am J Physiol 253:F299—F309,
1987
300
250
200
0
ci)>
cci
a)
150
100
8-Br-cAMP
Forskolin
Fig. 7. Inhibition of Ang Il-stimulated MAP kinase by 8-bromo-cAMP and
forskolin. Incubation of OK cells with Ang II in the presence of 8-bromo-
cAMP or forskolin resulted in significant decrease MAP kinase activity
(N = 5, mean SEM).
Terada et al: Activation of MAP kinase in OK cells 1809
5. WOLF G, MUELLER E, STAHL RAK, ZIYADEH FN: Angiotensin
TI-induced hypertrophy of cultured murine proximal tubular cells is
mediated by endogenous transforming growth factor-li J Clin Invest
92:1366-1372, 1993
6. TERADA Y, TOMITA K, N0N000cHI H, MARUMO F: PCR localization
of angiotensin tT receptor and angiotensinogen mRNAs in rat kidney.
Kidney mt 43:1251—1259, 1993
7. GRONE HJ, SIMON M, FUSI-IS E: Autoradiographic characterization of
angiotensin receptor subtypes in fetal and adult human kidney. Am J
Physiol 262:F326—F311, 1992
8. CHOU AT, HERBLIN WF, MCCALL DE, ARDECKEY Ri, CARINI DJ,
DUNCIA JV, PEASE U, WONG PC, WEXLER RR, JOHNSON AL,
TIMMERMANS RPMWM: Identification of angiotensin II receptor
subtypes. Biochem Biophys Res Commun 165:196—202, 1989
9. SECHI LA, GRADY EF, GRIFFIN CA, KALINYAK JE, SCHAMBELAN M:
Distribution of angiotensin II receptor subtypes in rat and human
kidney. Am J Physiol 262:F236—F240, 1992
10. WOODCOCK EA, JOHNSON CT: Inhibition of adenylate cyclase by
angiotensin II in rat renal cortex. Endocrinology 111:1687—1691, 1982
11. SMITH RD: Comparison of the responses of three rat intestinal
epithelial cell lines to angiotensin IT. Cell Biol mt 18:737—745, 1994
12. MOLLOY CJ, TAYLOR DS, WEBER H: Angiotensin II stimulation of
rapid protein tyrosine phosphorylation and protein kinase activation
in rat aortic smooth muscle cells. J Biol Chem 268:7338—7345, 1993
13. HUCKLE WR, PROKOP CA, DY RC, HERMAN B, EARP 5: Angiotensin
II stimulates protein-tyrosine phosphorylation in a calcium-dependent
manner. Mol Cell Biol 10:6290—6298, 1990
14. FORCE T, KYRIAKIS JM, AVRUCH J, BONVENTRE JV: Endothelin,
vasopressin, amd angiotensin II enhance tyrosine phosphorylation by
protein kinase C-dependent and -independent pathways in glomerular
mesangial cells. J Biol Chem 266:6650—6656, 1991
15. TSUDA T, KAWAHARA Y, ISHIDA Y, KOIDE M, SI-Ill K, YOKOYAMA M:
Angiotensin II stimulates two myelin basic protein/microtubule-asso-
ciated protein 2 kinases in cultured vascular smooth muscle cells. Circ
Res 71:620—630, 1992
16. ROBERTS TM: A signal chain of events. Nature 360:534—535, 1992
17. AnN NO, KREBS EG: Evidence for an epidermal growth factor-
stimulated protein kinase cascade in Swiss 3T3 cells. J Biol Chem
256:11495—11501, 1990
18. POSADA J, COOPER JA: Requirements for phosphorylation of MAP
kinase during meosis in Xenopus oocytes. Science 255:212—215, 1992
19. LANGE-CARTER CA, PLEIMAN CM, GARDNER AM, BLUMER U,
JOHNSON GL: A divergence in the MAP kinase regulatory network
defined by MEK kinase and raf. Science 260:315—319, 1993
20. CREWS CM, ERIKSON RL: Extracellular signals and reversible protein
phosphorylation: What to Mek of it all. Cell 74:215—217, 1993
21. HUGHES DA, ASHWORTH A, MARSHALL Ci: Complementation of byrl
in fission yeast by mammalian MAP kinase kinase requires coexpres-
sion of Raf kinase. Nature 364:349—352, 1993
22. NGUYEN IT, SCIMECA JC, FILLOUX C, PEPALDI P, CARPENTIER JL:
Van Obberghen E: Co-regulation of the mitogen-activated protein
kinase, extracellular signal-regulated kinase 1, and the 90-kDa ribo-
somal S6 kinase in PC12 cells. J Biol Chem 268:9803—9810, 1993
23. ANDERSON NG, MALLER JL, TONKS NK, STURGILL TW: Requirement
for integration of signals from two distinct phosphoiylation pathways
for activation of MAP kinase. Nature 343:651—653, 1990
24. THOMAS G, MARTIN-PEREZ J, SIEGMANN M, Orro AM: The effect of
serum, EGF, PGF2 alpha and insulin on S6 phosphorylation and the
initiation of protein and DNA synthesis. C'ell 30:235—242, 1982
25. CAVERZASIO J, RIZZOLI R, BONJOUR JP: Sodium-dependent phos-
phate transport inhibited by parathyroid hormone and cyclic AMP
stimulation in an opposum kidney cell line, J Biol Chem 261:3233—
3237, 1986
26. JOURDAIN M, AMIEL C, FRIEDLANDER G: Modulation of Na-H
exchange activity by angiotensin II in opossum kidney cells. Am J
Physiol 263:C1141—C1146, 1992
27. MEIER KE, LICCIARDI KA, HAYSTEAD TAJ, KREBS EG: Activation of
messenger-independent protein kinases in wild-type and phorbol
ester-resistant ETA thymoma cells. J Biol Chem 266:1914—1920, 1991
28. SIEGEL JN, KLAUSNER RD, RAPP UR, SAMELSON LE: T cell antigen
receptor engagement stimulates c-raf phosphorylation and induces
c-raf associated kinase activity via a protein kinase C dependent
pathway. J Biol Chem 265:18472—18480, 1990
29. CARDONE MH, SMITH BL, SONG W, MOCHLY-ROSEN D, MosTov KE:
Phorbol myristate acetate-mediated stimulation of transcytosis and
apical recycling in MDCK cells. J Cell Biol 124:717—727, 1994
30. SOZERI 0, VOLLMER K, LJYANAGE M, FRITH D, KOUR G, MARK GE,
STABEL S: Activation of c-Raf protein kinase by protein kinase C
phosphorylation. Oncogene 7:2259—2262, 1992
31. PFEILSCHIErER J, BAUER C: Different effects of phorbol ester on
angiotensin II and stable GTP analogue-induced activation of
polyphosphoinositide phosphodiesterase in membranes isolated from
rat renal mesangial cells. Biochem J 248:209—215, 1987
32. ALAVI N, LIANOS EA, BENTZEL CJ: Prostaglandin and thromboxane
synthesis by highly enriched rabbit proximal tubular cells in culture. J
Lab Clin Med 110:338—345, 1987
33. Wu J, DENT P, JELINEK T, WOLFMAN A, WEBER MJ, STURGILL TW:
Inhibition of EGF-activated MAP kinase signaling pathway by aden-
osine 3', 5'-monophosphate. Science 262:1065—1069, 1993
34. HORDIIK PL, VERLAAN I, JALINK K, CORVEN EJ, MOOLENARWH:
cAMP abrogates the p21-mitogen-activated protein kinase pathway in
fibroblasts. J Biol Chem 269:3534—3538, 1994
35. GRAVES LM, BORNFELD KE, RAINES EW, Port-S BC, MACDONALD
SG, ROSS R, KREBS EG: Protein kinse A antagonizes platelet-derived
growth factor-induced signaling by mitogen-activated protein kinase
in human atrial smooth muscle cells. Proc NatI Acad Sci USA
90:10300-10304, 1993
36. HARRIS RC: Regulation of S6 kinase in renal proximal tubule. Am J
Physiol 263:F127—F134, 1992
37. WARD GE, KIRSCHNER MW: Identification of cell cycle-regulated
phosphorylation sites on nuclear lamin C. Cell 61:561—577, 1990
38. PULVERER BJ, KYRIAKIS JM, AVRUCH J, NIKOLAKAKI E, WOODGET1-
R: Phosphorylation of c-jun mediated by MAP kinases. Nature
353:670—674, 1991
39. CHEN RH, SARNECKI C, BLENIS J: Nuclear localization and regulation
of erk- and rsk-encoded protein kinases. Mol Cell Biol 12:915—927,
1992
40. SANGHERA JS, PETER M, NIGG EA, PELECH SL: Mitogen-activated
protein kinases phosphoiylate nuclear lamins and display sequence
specificity overlapping that of mitotic protein kinase p34cdc2. Mol Biol
Cell 3:775—787, 1992
